SENSORION news, videos and press releases - Page 4
For more news please use our advanced search feature.
SENSORION - More news...
SENSORION - More news...
- Sonova Invests €5 Million in Sensorion as the Companies Plan a Collaboration in Hearing Loss
- Sensorion Hosting Key Opinion Leader Call with Dr. John Greinwald on Genetic Hearing Loss in Children on December 2, 2020
- Sensorion Announces Attendance and a Presentation at Upcoming Conferences
- Sensorion and Novasep Announce Signature of a Gene Therapy Product Development and Manufacturing Agreement
- Sensorion reports 2020 first half results
- Sensorion Joins the EnterNext© PEA-PME 150 Index of Euronext Paris
- Sensorion Obtains €3 Million Loans, Including €2 Million Guaranteed by the French Government (PGE) and €1 Million as RDI Loan Through Bpifrance
- Sensorion Announces Attendance and Presentations at Upcoming Conferences
- Sensorion successfully raises approximately €31 (US$ 36.5) million in an oversubscribed private placement to US and European investors
- Sensorion Launches a Capital Increase by Means of an Accelerated Bookbuild Offering
- Sensorion Announces Attendance and Presentations at Upcoming Conferences
- Sensorion to present at the Oppenheimer Life Sciences Company Call Series and Virtual World Orphan Drug Congress USA
- Sensorion appoints five renowned experts to its Scientific Advisory Board
- Sensorion Will Present at the Bioprocessing Summit Europe Virtual Conference on July 21-23, 2020
- Sensorion Hosting Key Opinion Leader Call with Dr. Michael Hoffer on Sudden Sensorineural Hearing Loss and SENS-401 as a Potential Treatment Option on July 23, 2020
- Sensorion Appoints Dr Edwin Moses, Former Ablynx CEO, as Chairman of the Board
- Sensorion Announces Initiation of Coverage by US Investment Bank Chardan with a “Buy” Recommendation
- Sensorion Announces Positive Preliminary Preclinical Data From Its Otoferlin Gene Therapy Program
- Sensorion to attend Citi European Healthcare Conference
- Sensorion Publishes Results of General Assembly Resolutions
- Sensorion Announces It Will Hold Its General Assembly on May 20, 2020 Behind Closed Doors Alongside the Publication of Its 2019 Annual Financial Report
- Sensorion reschedules General Assembly to May 20
- Sensorion Reports Full-year 2019 Financial Results and Business Update
- Sensorion provides update on SENS-401 SSNHL Phase 2 AUDIBLE-S trial enrollment
- Sensorion appoints gene therapy expert Dr Géraldine Honnet as Chief Medical Officer
- Sensorion Receives Ethics Committee Approval to Include New Military Sites in SENS-401 Phase 2 study
- Sensorion Announces the Full Conversion of Sofinnova Partners Convertible Bonds Into Ordinary Shares
- Sensorion Announces the Full Conversion of Invus Convertible Bonds Into Ordinary Shares
- Sensorion to Attend and Present at LSX World Congress 2020
- Sensorion Presents New SENS-401 Preclinical Data at ARO Midwinter Meeting 2020
